Focus Rheums| ACR Convergence 2024 Previews

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Case Report: Is It Castleman Disease, or Castleman-Like?

Philip Chu, MD, RhMSUS, Mithu Maheswaranathan, MD, Jadee L. Neff, MD, PhD, & Rebecca E. Sadun, MD, PhD  |  Issue: October 2021  |  

Jadee L Neff, MD, PhDJadee L Neff, MD, PhD, is an assistant professor of pathology who subspecializes in hematopathology and molecular genetic pathology at Duke University School of Medicine, Durham, N.C. She is interested in biomarker discovery and assay development for diagnosis and therapeutic management of hematologic malignancy and mimics.

Rebecca E. Sadun, MD, PhDRebecca E Sadun, MD, PhD, is an adult and pediatric rheumatologist at Duke University School of Medicine, Durham, N.C., with an interest in how cognitive errors impact diagnostic reasoning in rheumatology.

ADVERTISEMENT
SCROLL TO CONTINUE

Disclosures

Dr. Neff is a consultant for EUSA Pharma and a participant in the company’s Peer to Peer Speaker’s Bureau regarding the criteria for pathologic diagnosis of Castleman disease.

References

  1. Fajgenbaum DC, Uldrick TS, Bagg A, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood. 2017 Mar;129(12):1646–1657.
  2. Wang L, Chen H, Shi J, et al. Castleman disease mimicking systemic lupus erythematosus: A case report. Medicine. 2018 Sep;97(38):e12291.
  3. Demirkan FG, Doğan S, Kalyoncu Uçar A, et al. Systemic lupus erythematosus complicated with Castleman disease: A case-based review. Rheumatol Int. 2021 Feb;41(2):475–479.
  4. Xia J-Y, Chen X-Y, Xu F, Yang Y, Wang H-Y, Xue J. A case report of systemic lupus erythematosus combined with Castleman’s disease and literature review. Rheumatol Int. 2012 Jul;32(7):2189–2193.
  5. Rhee F van, Voorhees P, Dispenzieri A, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018 Nov;132(20):2115–2124.

Related Articles

    Case Report: Diagnosing a Lupus-Flare Mimic

    The diagnosis of rheumatic diseases requires the exclusion of other systemic disorders. Infection, hematologic conditions, malignancies and some drugs may all lead to syndromes that closely mimic rheumatic diseases, which may lead to diagnostic delays. Idiopathic multicentric Castleman disease (iMCD) is a heterogeneous group of lympho­proliferative diseases (LPDs) characterized by systemic inflammatory manifestations.1,2 As with…

    Rheumatology Case Report: Concomitant Lupus with Features of Scleroderma, Castleman Disease

    We report a case of a 27-year-old woman who was initially diagnosed with systemic lupus erythematosus (SLE), had features of scleroderma and was subsequently found to have lymph node biopsy consistent with multicentric Castleman disease (MCD). She also had serologic evidence of acute Epstein-Barr virus (EBV) infection (vs. reactivation of EBV). The occurrence of MCD…

    A positron emission tomography (PET) scan shows a 3 cm, hypermetabolic mass adjacent to the stomach.

    Case Report: Elevated Inflammatory Markers & a Hypermetabolic Mass

    Consulting rheumatologists often assess patients with atypical clinical presentations for the possibility of an underlying rheumatic disease. Inflammatory syndromes that are not clearly rheumatic in nature can be particularly challenging to diagnose. Here, we share the case of a young woman with a long-standing undiagnosed illness and highly elevated inflammatory markers, and describe the evaluation…